Reaction
Thrombocytopenic Purpura reporting signals
As of the last recalculation, Thrombocytopenic Purpura appears in 1,364 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is QUININE (PRR 36.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Quinine | 20 | 36.1 | 36.2 |
| Panitumumab | 21 | 20.8 | 20.8 |
| Ado-Trastuzumab Emtansine | 10 | 18.2 | 18.2 |
| Atropine | 9 | 16.7 | 16.7 |
| Leucovorin Calcium | 19 | 15.4 | 15.4 |
| Atropine Sulfate | 10 | 14.2 | 14.2 |
| Aprepitant | 15 | 12.5 | 12.5 |
| Timolol Maleate | 8 | 12.4 | 12.4 |
| Fosaprepitant Dimeglumine | 11 | 12.3 | 12.3 |
| Fluorouracil Cream, 0.5% | 44 | 9.1 | 9.1 |
| Fluorouracil | 44 | 8.9 | 8.9 |
| Oxaliplatin | 35 | 7.4 | 7.4 |
| Romiplostim | 7 | 7.1 | 7.1 |
| Lapatinib | 7 | 6.9 | 6.9 |